Last reviewed · How we verify
NCT07589413
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
trial testing Measurement of Intraoperative Irrigation Fluid Absorption and Perioperative cfDNA Profiling in Bladder (Urothelial, Transitional Cell) Cancer in 150 participants. Currently enrolling.
Quick facts
| Lead sponsor | Zhiping Wang |
|---|---|
| Status | Recruiting now |
| Enrollment | 150 |
| Start date | 1 April 2026 |
| Estimated completion | 1 April 2027 |
Drugs / interventions tested
- Measurement of Intraoperative Irrigation Fluid Absorption and Perioperative cfDNA Profiling
Conditions studied
- Bladder (Urothelial, Transitional Cell) Cancer — all drugs for Bladder (Urothelial, Transitional Cell) Cancer →
- Bladder Cancer Recurrence — all drugs for Bladder Cancer Recurrence →
- Progression of Bladder Cancer — all drugs for Progression of Bladder Cancer →
- Transurethral Resection of Bladder Tumor — all drugs for Transurethral Resection of Bladder Tumor →
Sponsor
Zhiping Wang
Who can join
Eligibility, any sex, with Bladder (Urothelial, Transitional Cell) Cancer or Bladder Cancer Recurrence.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07589413
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bladder (Urothelial, Transitional Cell) Cancer
Currently open trials in the same condition.
- NCT07067749 — Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer · Phase 3 · recruiting
- NCT06787053 — Selecting Hypoxic Tumours for Treatment Modification · recruiting
- NCT06696742 — PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07589413 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhiping Wang
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07589413.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing